Q4 2021 13F Holders as of 12/31/2021
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
51.1M
-
Number of holders
-
162
-
Total 13F shares, excl. options
-
35.5M
-
Shares change
-
+2.05M
-
Total reported value, excl. options
-
$1.16B
-
Value change
-
+$58.3M
-
Put/Call ratio
-
0.64
-
Number of buys
-
83
-
Number of sells
-
-70
-
Price
-
$32.70
Significant Holders of REGENXBIO Inc. - Common Stock, par value $0.0001 per share (RGNX) as of Q4 2021
202 filings reported holding RGNX - REGENXBIO Inc. - Common Stock, par value $0.0001 per share as of Q4 2021.
REGENXBIO Inc. - Common Stock, par value $0.0001 per share (RGNX) has 162 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 35.5M shares
of 51.1M outstanding shares and own 69.38% of the company stock.
Largest 10 shareholders include BlackRock Inc. (6.57M shares), JPMORGAN CHASE & CO (5M shares), VANGUARD GROUP INC (4.05M shares), STATE STREET CORP (2.49M shares), Redmile Group, LLC (1.9M shares), RTW INVESTMENTS, LP (1.85M shares), Aquilo Capital Management, LLC (1.01M shares), Sofinnova Investments, Inc. (1.01M shares), DIMENSIONAL FUND ADVISORS LP (749K shares), and GEODE CAPITAL MANAGEMENT, LLC (668K shares).
This table shows the top 162 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.